Cheng‐Ming Chiang
- Virology top 2%
- Hematology top 5%
- Multiple Myeloma Research and Treatments 6
- Molecular Biology top 5%
- Protein Degradation and Inhibitors 16
- Ubiquitin and proteasome pathways 12
- Genomics and Chromatin Dynamics 7
- RNA Research and Splicing 4
- Histone Deacetylase Inhibitors Research 3
- Oncology top 10%
-
- T-cell and Retrovirus Studies 3
-
- Virus-based gene therapy research 5
- Co-authors
- A-Young LeeShwu‐Yuan WuRobert G. RoederThomas OelgeschlägerHsien‐Tsung LaiHong ZhangJongsook Kim KemperFatah Kashanchi
- Cited by
- VirologyHematologyMolecular Biology
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Cheng‐Ming Chiang
34 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 87
- Virology 223
- Hematology 239
- Molecular Biology 1.5k
- Oncology 339
- Immunology 192
Countries citing papers authored by Cheng‐Ming Chiang
This map shows the geographic impact of Cheng‐Ming Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Ming Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Ming Chiang more than expected).
Fields of papers citing papers by Cheng‐Ming Chiang
This network shows the impact of papers produced by Cheng‐Ming Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Ming Chiang. The network helps show where Cheng‐Ming Chiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng‐Ming Chiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2020 | 35 | |
| 9 | 2019 | 0 | |
| 10 | 2014 | 111 | |
| 11 | 2013 | 271 | |
| 12 | 2013 | 20 | |
| 13 | 2011 | 35 | |
| 14 | 2009 | 113 | |
| 15 | 2008 | 62 | |
| 16 | 2008 | 10 | |
| 17 | 2007 | 137 | |
| 18 | 1996 | 231 | |
| 19 | 1994 | 229 | |
| 20 | 1989 | 39 |
About Cheng‐Ming Chiang
Cheng‐Ming Chiang is a scholar working on Virology, Hematology and Molecular Biology, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (16 papers), Ubiquitin and proteasome pathways (12 papers), Genomics and Chromatin Dynamics (7 papers), Multiple Myeloma Research and Treatments (6 papers), Virus-based gene therapy research (5 papers), RNA Research and Splicing (4 papers), T-cell and Retrovirus Studies (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Virology (223 citations), Hematology (239 citations) and Molecular Biology (1.5k citations). Cheng‐Ming Chiang has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include A-Young Lee, Shwu‐Yuan Wu, Robert G. Roeder, Thomas Oelgeschläger, Hsien‐Tsung Lai, Hong Zhang, Jongsook Kim Kemper, Fatah Kashanchi, Graziella Piras and John Brady. Their work appears in journals such as Nature, Journal of Biological Chemistry and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.